NCT07164313View on ClinicalTrials.gov

A Study of ZW251 in Participants With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

May 31, 2028

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

ZW251

Administered intravenously

Trial Locations (1)

49546

RECRUITING

START Midwest, Grand Rapids

All Listed Sponsors

lead

Zymeworks BC Inc.

INDUSTRY